ArticleAdvances in therapy2025

Health State Utility Values in Fabry Disease: Insights from the Pegunigalsidase Alfa Clinical Trials.

Khashayar Azimpour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.